ANVISA registration
CARCINOEMBRYONIC (CEA)
Registration 80048490013. ANTÍGENO CARCINOEMBRIONÁRIO
Registration details
| Registration number | 80048490013 |
|---|---|
| Application number | 25351263877200654 |
| Technical name | ANTÍGENO CARCINOEMBRIONÁRIO |
| Risk class | III |
| Published on | 16/10/2006 |
| Validity | Expired on 16/10/2026 |
Registration holder
| Legal name | USA DIAGNOSTICA LTDA |
|---|---|
| CNPJ | 02.330.159/0001-08 |
Manufacturer
- MONOBIND INC. ESTADOS UNIDOS DA AMÉRICA
Other registrations held by USA DIAGNOSTICA LTDAview all
Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.
Next step
Medical device registration with ANVISA
HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.
Speak to a specialist